Literature DB >> 25541002

Combining cross-metathesis and activity-based protein profiling: new β-lactone motifs for targeting serine hydrolases.

Kaddy Camara1, Siddhesh S Kamat2, Celina C Lasota1, Benjamin F Cravatt3, Amy R Howell4.   

Abstract

β-Lactones are a privileged structural motif as enzyme inhibitors and chemical probes, particularly for the inhibition of enzymes from the serine hydrolase class. Herein, we demonstrate that cross-metathesis (CM) of α-methylene-β-lactones offers rapid access to structurally diverse, previously unexplored β-lactones. Combining this approach with competitive activity-based protein profiling (ABPP) identified lead β-lactone inhibitors/probes for several serine hydrolases, including disease-associated enzymes and enzymes of uncharacterized function. The structural diversity afforded by the α-methylene-β-lactone scaffold thus expands the landscape of serine hydrolases that can be targeted by small-molecule inhibitors and should further the functional characterization of enzymes from this class through the optimization of target-selective probes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ABPP; Cross metathesis; Serine hydrolases; α-Methylene-β-lactones; β-Lactones

Mesh:

Substances:

Year:  2015        PMID: 25541002      PMCID: PMC4279111          DOI: 10.1016/j.bmcl.2014.11.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  41 in total

1.  Activity-based protein profiling: the serine hydrolases.

Authors:  Y Liu; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras.

Authors:  Jin Xu; Christian Hedberg; Frank J Dekker; Qing Li; Kevin M Haigis; Eugene Hwang; Herbert Waldmann; Kevin Shannon
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

3.  Beta-lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes.

Authors:  Thomas Böttcher; Stephan A Sieber
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 4.  The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.

Authors:  Robert H Nelson; John M Miles
Journal:  Expert Opin Pharmacother       Date:  2005-11       Impact factor: 3.889

5.  Chemical modification and organelle-specific localization of orlistat-like natural-product-based probes.

Authors:  Peng-Yu Yang; Kai Liu; Chongjing Zhang; Grace Y J Chen; Yuan Shen; Mun Hong Ngai; Martin J Lear; Shao Q Yao
Journal:  Chem Asian J       Date:  2011-07-08

6.  Practical, catalytic, asymmetric synthesis of beta-lactones via a sequential ketene dimerization/hydrogenation process: inhibitors of the thioesterase domain of fatty acid synthase.

Authors:  Vikram C Purohit; Robyn D Richardson; Jeffrey W Smith; Daniel Romo
Journal:  J Org Chem       Date:  2006-06-09       Impact factor: 4.354

7.  A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.

Authors:  Jacqueline L Blankman; Gabriel M Simon; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2007-12

8.  Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.

Authors:  Shiva Kant; Ajay Kumar; Sukh Mahendra Singh
Journal:  Biochim Biophys Acta       Date:  2013-09-20

9.  Synthesis of novel beta-lactone inhibitors of fatty acid synthase.

Authors:  Robyn D Richardson; Gil Ma; Yatsandra Oyola; Manuel Zancanella; Lynn M Knowles; Piotr Cieplak; Daniel Romo; Jeffrey W Smith
Journal:  J Med Chem       Date:  2008-08-19       Impact factor: 7.446

10.  Remodeling natural products: chemistry and serine hydrolase activity of a rocaglate-derived β-lactone.

Authors:  Neil J Lajkiewicz; Armand B Cognetta; Micah J Niphakis; Benjamin F Cravatt; John A Porco
Journal:  J Am Chem Soc       Date:  2014-02-04       Impact factor: 15.419

View more
  9 in total

1.  Rh-Catalyzed Conjugate Addition of Aryl and Alkenyl Boronic Acids to α-Methylene-β-lactones: Stereoselective Synthesis of trans-3,4-Disubstituted β-Lactones.

Authors:  Christian A Malapit; Irungu K Luvaga; Donald R Caldwell; Nicholas K Schipper; Amy R Howell
Journal:  Org Lett       Date:  2017-08-15       Impact factor: 6.005

2.  Targeted Covalent Inhibition of Telomerase.

Authors:  Rick C Betori; Yue Liu; Rama K Mishra; Scott B Cohen; Stephen J Kron; Karl A Scheidt
Journal:  ACS Chem Biol       Date:  2020-02-24       Impact factor: 5.100

Review 3.  Strategies for Tuning the Selectivity of Chemical Probes that Target Serine Hydrolases.

Authors:  Franco Faucher; John M Bennett; Matthew Bogyo; Scott Lovell
Journal:  Cell Chem Biol       Date:  2020-07-28       Impact factor: 8.116

4.  Pd-Catalyzed Acyl C-O Bond Activation for Selective Ring-Opening of α-Methylene-β-lactones with Amines.

Authors:  Christian A Malapit; Donald R Caldwell; Nicole Sassu; Samuel Milbin; Amy R Howell
Journal:  Org Lett       Date:  2017-04-04       Impact factor: 6.005

Review 5.  The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids.

Authors:  Karthik Shanbhag; Amol Mhetre; Neha Khandelwal; Siddhesh S Kamat
Journal:  J Membr Biol       Date:  2020-08-07       Impact factor: 1.843

6.  Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay.

Authors:  Siddhesh S Kamat; Kaddy Camara; William H Parsons; Dong-Hui Chen; Melissa M Dix; Thomas D Bird; Amy R Howell; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2015-01-12       Impact factor: 15.040

7.  α-Methylene-β-Lactone Scaffold for Developing Chemical Probes at the Two Ends of the Selectivity Spectrum.

Authors:  Lei Wang; Louis P Riel; Bekim Bajrami; Bin Deng; Amy R Howell; Xudong Yao
Journal:  Chembiochem       Date:  2020-11-11       Impact factor: 3.164

8.  Mapping the Neuroanatomy of ABHD16A, ABHD12, and Lysophosphatidylserines Provides New Insights into the Pathophysiology of the Human Neurological Disorder PHARC.

Authors:  Shubham Singh; Alaumy Joshi; Siddhesh S Kamat
Journal:  Biochemistry       Date:  2020-06-03       Impact factor: 3.162

9.  Diversity Modification and Structure-Activity Relationships of Two Natural Products 1β-hydroxy Alantolactone and Ivangustin as Potent Cytotoxic Agents.

Authors:  Jiang-Jiang Tang; Qiu-Rui He; Shuai Dong; Xin Guo; Yu-Gong Wang; Bei-Lei Lei; Jun-Mian Tian; Jin-Ming Gao
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.